An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
Study found that a pill-in-the-pocket (PiP) strategy seems to be slightly less effective than antiarrhythmic drug therapy and in-hospital treatment but is associated with cost savings. A change in clinical practice that includes the introduction of PiP may save costs but also involves a reduction in clinical effectiveness compared to existing approaches used to treat patients with paroxysmal atrial fibrillation (PAF); however, there is insufficient evidence to support a recommendation for the use of PiP strategy in patients with PAF
1 Liverpool Reviews and Implementation Group (LRiG), Liverpool, UK
2 Liverpool Heart & Chest Hospital, Liverpool, UK
* Corresponding author Email:
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document